Mettler-Toledo International (NYSE:MTD) traded higher on Tuesday after UBS upgraded the U.S. life sciences company to Buy from Neutral, citing benefits from biopharma’s recent reshoring efforts and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback